logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
3/21/2019 9:10:04 AM Ligand To Receive $3 Mln Milestone Payment As Result Of FDA Approval Of Sage Therapeutics’ ZULRESSOTM Injection
2/7/2019 5:14:03 PM Ligand Pharma Q4 Loss/share $2.02 Vs. Loss $0.33 Year Ago
2/7/2019 9:00:35 AM Ligand Pharmaceuticals Enters Worldwide OmniAb Partnership With Genagon Therapeutics AB
2/4/2019 4:12:23 PM Ligand Announces Closing Investment In Dianomi Therapeutics
1/25/2019 9:02:35 AM Ligand Partner Seelos Therapeutics Becomes Public Company
1/24/2019 8:05:01 AM Seelos Therapeutics Completes Merger With Apricus Biosciences
1/16/2019 4:35:59 PM Rev. Fr. Emmanuel Lemelson Renews Calls For An Investigation In Ligand
12/18/2018 5:14:54 PM Ligand Pharmaceuticals Inc (LGND) Has Raised Its 2018 Revenue Estimate To $244 Mln From $240 Mln
12/18/2018 5:05:28 PM Ligand Pharmaceuticals Raises FY18 Outook; Now Expects Revenues Of Approx. $244 Mln And Adj. EPS Of Approx. $6.63
12/17/2018 4:02:21 PM Ligand Acquires Milestone And Royalty Rights To PTX-022 From Palvella Therapeutics
12/10/2018 10:03:02 AM Sermonix Announces FDA Acceptance Of IND Application On Phase 2 Trial Of Lasofoxifene
11/21/2018 9:01:12 AM Ligand Enters Worldwide OmniAb Partnership With IMetabolic Biopharma
11/8/2018 8:02:11 AM Ligand Pharma Q3 GAAP Net Income $67.4 Mln Or $2.80/shr Vs $8.4 Mln Or $0.36/Shr Last Year
10/10/2018 9:02:52 AM Ligand Pharma Closes Acquisition Of Vernalis
10/9/2018 12:05:15 PM Orchestra BioMed Adds Eric Rose, Jason Aryeh And Gary Pruden To Strategic Advisory Board